Kirsten Axelsen

Opinion author

Kirsten Axelsen is a biopharmaceutical consultant as well as a visiting scholar with the American Enterprise Institute and policy advisor to DLA Piper and Charles River Associates.

Pill coming out of jar forms a price increase graph. Cost of drugs on the rise. Healthcare costs and the high price of quality health care insurance concept. The cost of pills and tablets increasing. Vector illustration

Opinion

Look to Competition, Not Mandates, to Lower Drug Prices

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

August 20, 2025

4 min read

Kirsten Axelsen

U.S. Capitol surrounded by money and pill bottles/Taylor Tieden for BioSpace

Opinion

Don’t Import Bad Policy Ideas on Drug Pricing

Suggestions that the U.S. should emulate other countries on drug price controls or patents obscure how our present policies have allowed drug development to flourish.

November 13, 2024

4 min read

Kirsten Axelsen